CTM stock · TECH stock

CTM vs TECH · rev $44.8M vs P/E 65, rev $1.22B

Castellum Inc. (CTM) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.

Castellum Inc. (CTM) is a information technology services company listed on US.

Bio-Techne Corp (TECH) is a biotechnology company listed on US.

Latest reported CTM revenue for 2024-12-31 was $44.8M. Net income was -$10.0M. Revenue was down 1.1% from 2023-12-31 to 2024-12-31. CTM currently screens at market cap $67.0M.

Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.

CTM currently screens at market cap $67.0M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.

Not investment advice. Open the CTM and TECH stock pages for the full models.

Not investment advice.

Popular Stock Comparisons